Rockeby signs HK distributor
Monday, 12 January, 2004
Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau.
The unique test for vaginal candidiasis (thrush) -- a disease that affects 75 per cent of women at least once in their lifetime -- will be initially marketed there as a point of care test available from general practitioners, gynaecologists and obstetricians.
It has already been launched in several other Asia-Pacific markets including Australia, New Zealand, Singapore and Malaysia.
The Singapore- and Australia-based company listed on the ASX on December 23rd at AUD$0.20 and at the time of writing was trading at $0.245.
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
High folic acid in pregnancy could cause early bleeding
Women taking at least 800 micrograms of folic acid daily were more likely to report spotting and...
Genetics shape our personality and life outcomes more than we thought
Scientists have identified >1200 genetic variants associated with personality traits,...
